GTBPVSPECO• 7 Days (Normalized)
GTBP vs PECO (GT Biopharma Inc. vs Phillips Edison & Company Inc.)
Showing Closing Date Range from Sep 25 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.1
-11.47%
GT Biopharma Inc.
Normalized Baseline0.00%
PECO Performance $37.76
+0.99%
Phillips Edison & Company Inc.
Normalized Baseline0.00%
Alpha Spread Margin PECO LEADS
-12.46 pts
PECO outperforming by 12.46 percentage points
GTBPPECO
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP PECO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(4 dates)
| Date | GTBP Price | GTBP Gain (%) | PECO Price | PECO Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $6.10 | -11.47% | $37.76 | +0.99% | -12.46% |
| Sep 29, 2026 | $6.88 | -0.22% | $- | - | |
| Sep 28, 2026 | $6.80 | -1.31% | $37.54 | +0.40% | -1.71% |
| Sep 25, 2026 | $6.89 | +0.00% | $37.39 | +0.00% | +0.00% |